ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.96 USD
11.71%
Updated:
Apr 18, 2024
ADC Therapeutics SA
Total Receivables
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Total Receivables Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Receivables
$25.2m
|
CAGR 3-Years
162%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Total Receivables
CHf15.7m
|
CAGR 3-Years
102%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Receivables
$200m
|
CAGR 3-Years
1 160%
|
CAGR 5-Years
357%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Receivables
CHf58.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
23%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Receivables
CHf49.3m
|
CAGR 3-Years
102%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Receivables
CHf7.6m
|
CAGR 3-Years
76%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Total Receivables?
Total Receivables
25.2m
USD
25.2m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Total Receivables amounts to 25.2m USD.
What is ADC Therapeutics SA's Total Receivables growth rate?
Total Receivables CAGR 5Y
71%
71%
Over the last year, the Total Receivables growth was -66%. The average annual Total Receivables growth rates for ADC Therapeutics SA have been 162% over the past three years , 71% over the past five years .
You don't have any saved screeners yet
